Intestinal liner holds promise for obesity, type 2 diabetes

09/18/2011 | InternalMedicineNews.com (free registration)

A small study presented at the European Society for the Study of Diabetes found that using a duodenal-jejunal bypass liner, an implantable weight-loss device, helped improve weight and blood glucose levels in obese patients with type 2 diabetes. The intestinal sleeve also increased the levels of incretin hormones glucagon-like peptide and peptide YY.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ